• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 16 of 19
Key Speakers At The Stanford Institute For Economic Policy Research Forum
LeadershipGilead CEO John Martin Is Stepping Down After 20 Years
By Jen WiecznerJanuary 29, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceBiotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
HealthBiosimilars Are Coming After Big Pharma’s Bottom Line
By Laura LorenzettiJanuary 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
HealthShire-Baxalta $32 Billion Merger Talks Said to Advance
By Michal AddadyJanuary 3, 2016
Biotech’s Insane Year
HealthBiotech’s Insane Year
By Laura LorenzettiDecember 31, 2015
Inside of a Gilead Sciences Lab
FinanceIsis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price
By Jen WiecznerDecember 18, 2015
Packs of Wrigley chewing gum are displayed in Westerville, O
TechDoublemint Gum Is an Awesome Biosensor
By Hilary BrueckDecember 3, 2015
MSMB Capital Management CIO Martin Shkreli
FinanceTuring CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
CNBC Events - Clinton Global Initiative 2015
TechA Theranos Deal With Safeway Stores May be Falling Apart
By Daniel RobertsNovember 11, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthAstrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
MSMB Capital Management CIO Martin Shkreli
HealthThis super-expensive drug is getting a $1 rival
By Benjamin SnyderOctober 23, 2015
Big pharma won’t stay silent in drug pricing debate for long
HealthBig pharma won’t stay silent in drug pricing debate for long
By Erika FryOctober 22, 2015
Biogen Idec Inc. CEO George Scangos Interview
HealthProfits up, Biogen cuts 11% of global workforce
By Erika FryOctober 21, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
CommentaryClinton’s big pharma takedown plan has some serious issues
By Chris Ford and Bethany CiancioloOctober 16, 2015
Theranos controversy has little to do with ‘unicorns’
TechTheranos controversy has little to do with ‘unicorns’
By Dan PrimackOctober 15, 2015
1...
  • 14
  • 15
  • 16
  • 17
  • 18
19
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Personal Finance
Current price of oil as of June 23, 2026placeholder alt text
By Joseph HostetlerJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.